Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 25 trials

Success Rate

100.0%

+13.5% vs benchmark

Late-Stage Pipeline

32%

8 trials in Phase 3/4

Results Transparency

9%

1 of 11 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

16Total
Not Applicable (6)
P 2 (2)
P 3 (2)
P 4 (6)

Trial Status

Completed11
Recruiting6
Unknown4
Not Yet Recruiting3
Withdrawn1

Trial Success Rate

100.0%

Benchmark: 86.5%

Based on 11 completed trials

Clinical Trials (25)

Showing 20 of 20 trials
NCT07500922Not ApplicableRecruiting

Menopause Effects on Cortico-reticular Functioning

NCT07394049Not Yet RecruitingPrimary

Impact of New Hormone Replacement Therapy After Menopause on Heart Health in Women

NCT06372119Not ApplicableRecruiting

Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)

NCT04478760Completed

Trans & Non-binary Reference Intervals While on Hormone Therapy Study

NCT05166083Completed

Investigation of the Perceptual and Acoustic Voice in Trans Man

NCT06905886Not Yet Recruiting

Resting Energy Expenditure in Postmenopausal Women

NCT06357442Recruiting

Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.

NCT06710496Not Yet Recruiting

HISTOLOGICAL RESULTS IN TRANSGENDER INDIVIDUALS ASSIGNED TO FEMALES AT BIRTH UNDERGOING GENDER AFFIRMATION SURGERY AND IN TESTOSTERONE THERAPY

NCT06570460Phase 4Recruiting

Long Term Effects of Oral Versus Transdermal Estrogen Replacement Therapy in Turner Syndrome

NCT06544473Phase 4Recruiting

Determining Dose Equivalence Between Oral and Transdermal Estrogen Treatment in Women With Turner Syndrome

NCT04758871Phase 4Completed

Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles

NCT06353555Not ApplicableRecruiting

Efficacy of Thyroid Hormone Replacement for Secondary Hypothyroidism Following Intracerebral Hemorrhage

NCT05168865Phase 4Withdrawn

Letrozole Versus Hormonal Preparation in Frozen Cycles of PCOS Patients.

NCT05774405Phase 2Completed

Short-term Effects of Transdermal Estradiol on Female COVID-19 Patients

NCT04742816Phase 4Completed

Renal Effects of Hormones/Biomarkers in Transgender PrEP Recipients

NCT05122065Unknown

Menopausal Vaginal Microbiome

NCT05072756Completed

Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits

NCT04503915Not ApplicableUnknownPrimary

Estrogen Supplementation Mode in HRT-FET Cycle: a RCT

NCT04453332Not ApplicableUnknown

Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters

NCT00012909Not ApplicableCompleted

Development and Evaluation of a Hormone Replacement Therapy Decision-Aid

Scroll to load more

Research Network

Activity Timeline